Study identifier:D3461R00089
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Generating Evidence Study for Systemic Lupus Erythematosus using different types of methodologies
Systemic Lupus Erythematosus
Phase 4
No
-
All
1000
Observational
18 Years - 100 Years
Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Nov 2024 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|